Isolation and characterization of Streptococcus agalactiae in pregnant women;Isolamento e caratterizzazione di Streptococcus agalactiae in donne gravide

Giornale Italiano di Ostetricia e Ginecologia

Volumn 30, Issue 10, 2008, Pages 301-306

  Roccasalva, L S ^a   Giummarra, V ^a   Valenti, O ^a   Scuderi, M C ^a   Furneri, P M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antibiotic prophylaxis; Antibiotic resistence; Culture based screening; GBS; Maternal colonisation; Pathogenesis

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; PROTEIN ALP; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOFILM; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFECTION PREVENTION; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PREGNANT WOMAN; PREVALENCE; PUERPERIUM; SCREENING TEST; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

EID: 61849122839     PISSN: 03919013     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BAKER CJ, BARRETT FF, GORDON RC, YOW MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973; 82: 724-9.
2. BARTON LL, FEIGIN RD, LINS R. Group B beta hemolytic streptococcal meningitis in infants. J Pediatr 1973; 82: 719-23.
3. FRANCIOSI RA, KNOSTMAN JD, ZIMMERMAN RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973; 82: 707-18.
4. MCCRACKEN GH. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973;82:703-6.
5. BALDASSARI L. Infezioni da streptococco di gruppo B. Roma: Istituto Superiore di Sanità (2007). (Rapporti ISTISAN 07/28).
6. GHERARDI G, IMPERI M., BALDASSARRI L, PATARACCHIA M, ALFARONE G, RECCHIA, OREFICI G, DICUONZO G, CRETI R. Molecular epidemiology and distribution of serotypes, surface protein, and antibiotic resistence among Group B streptococci in Italy. J Clin Microbiol Sept 2007; 45: 2909-16.
7. ROSENAU A, MARTINS K, AMOR S, GANNIER F, LANOTTE P, VAN DER MEE-MARQUET N, MEREGHETTI L, QUENTIN R.. Evalution of the ability of Streptococcus agalactiae strains isolated from genital and neonatal speciments to bind to human fibrinogen and correlation with characteristics of the fbsA and fbsB genes. Infect Immun 2007; 75: 1310-17.
8. PRAKASH B, VEEREGOWDA BM, KRISHNAPPA G. Biofilms: a survival strategy of bacteria. Curr. Sci. 2003; 85: 1299-307.
9. CVITKOVITCH G, YUNG-HUA LI Y-H, ELLEN RP. Quorum sensing and biofilm formation in streptococcal Infections. J Clin Invest 2003; 112: 1626-32.
10. BALDASSARRI L, CRETI R, OREFICI G. Le infezioni da streptococco di gruppo B in Italia. Un problema importante per la salute della donna e del bambino. Not. Ist. Sup. Sanità 2007; 20: 8-11
11. PATTERSON MJ, EL BATOOL HAFEEZ A. Group B streptococci in human disease. Bacteriol Rev. 1976; 40: 774-92
12. PETTERSSON K. Perinatal infection with Group B streptococci. Semin Fetal Neonatal Med 2007; 12: 193-7.
13. HAMMERSCHLAG MR, BAKER CJ, ALPERT S, KASPER DL, ROSNER I, THURSTON P, WEBB BJ, MCCORMACK WM. Colonization with group B streptococci in girls under 16 years of age. Pediatrics 1977; 60: 473-6.
14. ZANGWILL KM, SCHUCHAT A, WENGER JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 1992; 41: 25-32.
15. SCHRAG SJ, ZYWICKI S, FARLEY MM, REINGOLD AL, HARRISON LH, LEFKOWITZ LB, HADLER JL, DANILA R, CIESLAK PR, SCHUCHAT A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20
16. REGAN JA, KLEBANOFF MA, NUGENT RP, ESCHENBACH DA, BLACKWELDER WC, LOU Y, GIBBS RS, RETTIG PJ, MARTIN DH, EDELMAN R. Colonization with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol 1996; 174: 1354-60.
17. SCHRAG S, GORWITZ R, FULTZ-BUTTS K, SCHUCHAT A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1-22.
18. LIJOI D, DI CAPUA E, FERRERO S, MISTRANGELO E, GIANNATTASIO A, MORANO S, RAGNI N. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet 2007; 275: 373-79.
19. GARLAND SM, FLIEGNER JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust NZ J Obstet Gynaecol 1991; 31: 119-22
20. BOYER KM, GOTOFF SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665-9.
21. CLINICAL AND LABORATORY STANDARDS INSTITUTE. Performance Standard for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, 940 West Vallery Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2007.
22. COMITE DE ANTIBIOGRAMME DE LA SOCIETE FRANCAISE DE MICROBIOLOGIE. Statement 1996 CAMSF. Zone sizes and breakpoints for nonfastidious organism. Clin Microbiol Infect 1996; 2: S46-9.
23. PRUKSAKORN S, SITTISOMBUT N, PHORNPHUTKUL C, PRUKSACHATKUNAKORN C, GOOD MF, BRANDT E. Epidemiological Analysis of Non-M-Typeable Group A Streptococcus isolates from a Thai population in northern Thailand. J. Clin. Microbiol 2000; 38:1250-1254
24. SUTCLIFFE J, GREBE T, TAIT-KAMRADT A, WONDRACK L. Detection of Eritromycin-Resistant Determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-66.
25. SEPPALA H, SKURNIK M, SOINI H,. ROBERTS MC, HUOVINEN P. A novel Erythromycin resistance methylase Gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents and Chemother 1998; 42: 257-62.
26. ROBERTS MC, SUTCLIFFE J, COURVALIN P, JENSEN LB, ROOD J, SEPPALA H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents and Chemother,. 1999; 43: 2823-30.
27. GHERARDI G, IMPERI M, BALDASSARRI L, PATARACCHIA M, ALFARONE G, RECCHIA S, OREFICI G, DICUONZO G, CRETI R. Molecular epidemiology and distribution of serotypes, surface protein, and antibiotic resistence among Group B Streptococci in Italy. J Clin Microbiol 2007; 45: 2909-16.
28. POYART C, TAZI A, REGLIER-POUPET H, BILLOET A, TAVARES N, RAYMOND J, TRIEU-CUOT P. Multiplex PCR assay for rapid and accurate capsular typing of Group B Streptococci. Journal of Clinical Microbiology, June 2007, 45:1985-88.
29. CRETI R, FABRETTI F, OREFICI G, VON HUNOLSTEIN C. Multiplex PCR assay for direct identification of Group B Streptococcal alpha-protein-like protein genes. J Clin Microbiol 2004; 42: 1326-29.
30. RAMASWAMY SV, FERRIERI P, MADOFF LC, FLORES AE, KUMAR N, TETTELIN H, PAOLETTI LC. Molecular characterization of nontypeable Group B Streptococcus. J Clin Microbiol 2006; 44: 2398-403.
31. TRIJBELS-SMEULDERS MA, KOLLÉE LA, ADRIAANSE AH, KIMPEN JL, GERARDS LJ. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004; 23: 172-3.
32. KADANALI A, ALTOPARLAK U, KADANALI S. Maternal carriage and neonatal colonisation of group B streptococcus in eastern Turkey: prevalence, risk factor and antimicrobial resistence Int J Clin Pract 2005; 59: 437-40
33. CAMPBELL JR, HILLIER SL, KROHN MA, FERRIERI P, ZALEZNIK DF, BAKER CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at welivery. Obstet Gynecol. 2000; 96: 498-503
34. BALDASSARRI L, CRETI R, RECCHIA S, IMPERI M, FACINELLI B, GIOVANETTI E, PATARACCHIA M, ALFARONE G, OREFICI G. Therapeutic gailures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 2006; 44: 2721-27.